China and Global E-cigarette Industry: Opportunities and Challenges

Feb.09.2023
China and Global E-cigarette Industry: Opportunities and Challenges
Chinese e-cigarette industry has room to grow both domestically and globally, with emphasis on brand-building and exports.

According to the news from the Wisdom Finance and Economics app, Guoyuan Hong Kong has released a research report stating that the domestic and global electronic cigarette industries are still in the early stages of penetration rate improvement, and the long-term trend of improving penetration rates is certain. Domestic e-cigarette sales are currently under short-term pressure, but are expected to improve compared to the fourth quarter of 2022, with short-term potential depending on regulatory practices. The overseas market, including the United States, is expected to usher in a policy clearance in 2023. Manufacturing companies with overseas production capacity layout advantages and global production capacity operation and management capabilities will have a competitive advantage in the future. The firm believes that relying on the advantage of the supply chain, branding e-cigarettes for overseas markets will be an important investment opportunity. It will focus on the leading brand Wuxin Technology (RLX.US), and pay attention to the manufacturing leader SMIC International (06969).


The main viewpoints of Guoyuan Hong Kong are as follows:


Domestic Market: Short-term Pressure on Domestic Sales, China's E-Cigarette Supply Chain Possesses Irreplaceable Advantages.


(1) Domestic Market: With the implementation of regulatory policies in 2022, the electronic cigarette industry in China will enter a period of legalization and orderly development. However, with flavor restrictions, license requirements, and consumption taxes, the domestic electronic cigarette market may experience short-term pressure. It is expected to recover in 2023, but this depends on regulatory practice. In the medium to long term, the industry will favor the stronger players under strict regulations, as it is still in its early stages of penetration. With harm reduction and smoke substitution features, the medium to long-term trend in industry penetration is expected to continue. (2) Overseas Market: China supplies 95% of the global electronic cigarette market, which gives the Chinese electronic cigarette industry an irreplaceable advantage in technology research and development, product design, and manufacturing. Policies encourage electronic cigarette companies to export and generate income, with electronic cigarette manufacturing for international brands being the main source of revenue. Leveraging this supply chain advantage, branding electronic cigarettes for international markets will be an important business opportunity in this phase.


Global: Increasing penetration rate, mid-term market worth billions of dollars, regulatory trends becoming more organized.


In 2021, the global vape and heat-not-burn (HNB) industries had sizes of $22.8 billion and $28.8 billion, respectively, representing penetration rates of only 2.9% and 3.7% based on their respective sizes. However, due to their harm-reducing properties, the mid- to long-term trend is expected to see an increase in penetration rates. The most critical variable determining the development of these industries is regulatory policies.


(1) Worldwide regulations are becoming stricter, but this will not change the long-term development trend of new tobacco products. The direction of regulation is to encourage the industry to return to the essence of harm reduction, and stricter regulation trends benefit industry leaders. The United States has a strict and high threshold, Europe is relatively lenient, Japan prohibits nicotine-containing vapes but supports HNB, and some Southeast Asian countries have lenient regulations. (2) The characteristics of the US regulatory system serve as a model for global regulation: (1) FDA PMTA has a high threshold and requires a full chain pre-market review; (2) flavor restrictions (FDA bans the sale of vapes other than tobacco and menthol flavors, but so far no menthol vape product has been approved; California currently only allows tobacco-flavored vapes and bans flavored ones); (3) in regulatory practice, PMTA emphasizes the harm reduction and safety stability of products, and has a higher tolerance for product forms.


Pay close attention to investment opportunities related to the branding of electronic cigarettes for expansion overseas.


(1) Brand side: Leveraging high-quality supply chains, electronic cigarette branding goes global in its golden age. Looking back at China's advantageous supply chains in industries such as daily light industry and consumer electronics, brands like Miniso, Huawei, and Xiaomi have evolved into global brands leveraging high-quality supply chains. Chinese electronic cigarette brands that have strong product capabilities and branding capabilities while adhering to compliance standards have the opportunity to emerge as winners in this competition.


Manufacturing side: China's share in the global electronic cigarette manufacturing market is extremely high (over 90%), therefore, the growth of China's electronic cigarette manufacturing industry mainly depends on global market expansion. In the future, manufacturing companies with advantageous overseas production layout and global production and operation management capabilities will gain a competitive edge.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
UK HMRC Urges Public to Report Suspicious Vape Shops in Crackdown on Tax Fraud, Money Laundering and Illicit Tobacco Sales
UK HMRC Urges Public to Report Suspicious Vape Shops in Crackdown on Tax Fraud, Money Laundering and Illicit Tobacco Sales
HM Revenue & Customs is urging members of the public to report vape shops, barber shops and other high-street businesses suspected of tax fraud, money laundering or other illegal activity, with informants not required to provide personal details. HMRC plans more than 30,000 interventions in 2026-27 targeting tax fraud, organised crime and illicit activity, including the sale of illegal vapes and tobacco. The push forms part of a broader UK effort to tackle organised crime on high streets, backed by a £30 million government enforcement programme.
Regulations
Aug.17 by 2Firsts Perspectives
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
BAT CFO Dragos Constantinescu Takes Office, Returning After Seven Years and Former Asahi Europe Leadership Role
BAT CFO Dragos Constantinescu Takes Office, Returning After Seven Years and Former Asahi Europe Leadership Role
Dragos Constantinescu has officially taken up his role as Chief Financial Officer and Executive Director at British American Tobacco (BAT). He previously spent 16 years at BAT across finance and general management roles in Europe before joining Asahi in 2019 and becoming CEO of Asahi Europe & International in 2025. His return comes as BAT continues to advance its “A Better Tomorrow” transformation.
BAT
Sep.01
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07